Form 4: Teladoc Health Executive Stephany Verstraete Reports Stock Transactions
SEC Form 4 Filing
Chief Marketing Officer Stephany Verstraete reports acquisition and disposal of Teladoc Health stock units and shares to cover tax obligations.
Summary
- Stephany Verstraete, Chief Marketing Officer of Teladoc Health, reported transactions involving Teladoc Health's common stock.
- On August 30, 2024, Verstraete acquired 1,109 shares through the conversion of performance stock units, 1,404 shares through restricted stock units, and 3,255 shares through restricted stock units.
- On September 3, 2024, Verstraete sold 2,083 shares at a price of $7.164 per share.
- These sales were to cover tax withholding obligations related to the vesting of performance stock units and restricted stock units.
- Following these transactions, Verstraete directly owns 48,843 shares of Teladoc Health common stock.
- Verstraete also holds derivative securities including 6,658 Performance Stock Units, 2,808 Restricted Stock Units from a 2022 grant, and 19,532 Restricted Stock Units from a 2023 grant.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect the overall health or prospects of Teladoc Health but offers insight into individual executive actions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by an executive.
- The sale of shares to cover tax obligations is a common practice and doesn't necessarily indicate a lack of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/01/2022 | Reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2023 | Reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/01/2024 | One-third of the 39,063 restricted stock units granted on March 3, 2023 vested. |
| 08/30/2024 | Acquisition of shares through conversion of performance stock units and restricted stock units. |
| 09/03/2024 | Sale of shares to cover tax withholding obligations. |
| 09/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.